Form 8-K - Current report:
SEC Accession No. 0001193125-25-151281
Filing Date
2025-06-27
Accepted
2025-06-27 16:16:25
Documents
13
Period of Report
2025-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d84939d8k.htm   iXBRL 8-K 30584
2 EX-10.1 d84939dex101.htm EX-10.1 760960
  Complete submission text file 0001193125-25-151281.txt   1072038

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lh-20250627.xsd EX-101.SCH 2845
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lh-20250627_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lh-20250627_pre.xml EX-101.PRE 10811
15 EXTRACTED XBRL INSTANCE DOCUMENT d84939d8k_htm.xml XML 3484
Mailing Address 358 S MAIN ST BURLINGTON NC 27215
Business Address 358 S MAIN ST BURLINGTON NC 27215 3362291127
LABCORP HOLDINGS INC. (Filer) CIK: 0000920148 (see all company filings)

EIN.: 992588107 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11353 | Film No.: 251086542
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)